Baum L. Mark's Insider Trades & SAST Disclosures
Baum L. Mark's most recent trade in Harrow Health Inc was a trade of 762,300 Common Stock done . Disclosure was reported to the exchange on April 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Baum L. Mark.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 762,300 | 2,899,825 (11%) | 3% | 0 | Common Stock | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 762,300 | 0 | - | - | Performance Stock Unit | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 03 Apr 2025 | 300,363 | 2,599,462 (10%) | 1% | 23.1 | 6,935,382 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 11.59 per share. | 22 Mar 2024 | 9,000 | 2,137,525 (8%) | 0% | 11.6 | 104,310 | Common stock |
| Harrow Health Inc | Baum L. Mark | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 150,000 | 0 | - | - | RSU | |
| Harrow Health Inc | Baum Mark L. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.67 per share. | 20 Feb 2024 | 150,000 | 2,188,361 (8%) | 0% | 10.7 | 1,600,500 | Common stock |
| Harrow Health Inc | Mark Baum L. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.67 per share. | 20 Feb 2024 | 59,836 | 2,128,525 (8%) | 0% | 10.7 | 638,450 | Common stock |
| Harrow Health Inc | L. Baum Mark | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 15,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Harrow Health Inc | Baum Mark L. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.71 per share. | 07 Feb 2024 | 15,400 | 2,038,361 (8%) | 0% | 7.7 | 118,734 | Common stock |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 17.05 per share. | 14 Aug 2023 | 5,800 | 2,015,461 (8%) | 0% | 17.1 | 98,890 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2023 | 762,300 | 2,309,629 (9%) | 3% | - | Common Stock | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2023 | 762,300 | 0 | - | - | Performance Stock Unit | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.23 per share. | 18 Jul 2023 | 299,968 | 2,009,661 (7%) | 1% | 18.2 | 5,468,417 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 762,300 | 762,300 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.99 per share. | 03 Apr 2023 | 180,000 | 1,664,962 (6%) | 0% | 9.0 | 1,618,200 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 180,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.97 per share. | 03 Apr 2023 | 117,633 | 1,547,329 (6%) | 0% | 21.0 | 2,466,764 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 88,000 | 1,520,141 (6%) | 0% | - | Common Stock | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 88,000 | 0 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.76 per share. | 02 Jan 2023 | 35,179 | 1,484,962 (5%) | 0% | 14.8 | 519,242 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 13.39 per share. | 22 Dec 2022 | 25,000 | 1,432,141 (5%) | 0% | 13.4 | 334,750 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2021 | 762,301 | 762,301 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2021 | 850,000 | 0 | - | - | Restricked Stock Unit | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2021 | 850,000 | 1,687,676 (6%) | 3% | 0 | Common Stock | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.26 per share. | 25 Apr 2021 | 334,129 | 1,353,547 (5%) | 1% | 8.3 | 2,759,906 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 200,000 | 850,000 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 200,000 | 837,676 (3%) | 0% | - | Common Stock | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 150,000 | 150,000 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Jun 2020 | 600,000 | 0 | - | - | Employee Stock Option - Right to Buy | |
| Harrow Health Inc | Mark L. Baum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 600,000 | 600,000 | - | - | Employee Stock Option - Right to Buy |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges